Literature DB >> 16766138

Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users.

Eddy Ríos-Olivares1, Luis M Vilá, Juan C Reyes, José W Rodríguez, J Héctor M Colón, Nat O Pagán, Amalia Marrero, Zilka M Ríos-Orraca, Nawal M Boukli, Paul Shapshak, Rafaela R Robles.   

Abstract

HCV-infected "speedball" users (n = 30) were selected from an original cohort of 400 intravenous drug users for cytokine analysis. Cytokine concentrations (TNF-alpha, IL-1beta, IL-6, IFN-gamma, IL-2, IL-4, IL-10 and IL-12) were determined in plasma and peripheral blood mononuclear cells (PBMC) cultures derived ex vivo from these patients. In addition, lymphocyte proliferation was measured in 49 HCV-positive "speedball" users. TNF-alpha, IL-6, IFN-gamma, IL-2, IL-4, IL-10, IL-12 cytokines and not IL-1beta were significantly increased in plasma from HCV-positive "speedball" users compared with healthy controls. Except for IL-10, all other cytokines measured were augmented in phytohemagglutinin-stimulated PBMC cultures from HCV-positive "speedball" users. Likewise, overproduction of cytokines TNF-alpha, IL-1beta, IL-6 and IFN-gamma, was consistently detected when PBMC cultures from HCV-positive "speedball" users were stimulated with a biological response modifier. However, HCV-infected "speedball" users showed significant reduction in lymphoproliferative activity. Compared with healthy subjects, there was a consistent overproduction of both TH1 and TH2 type cytokines in the plasma and PBMC's of HCV-infected "speedball" users. Furthermore, there was a persistent reduction of lymphoproliferative activity in this group. These immunologic abnormalities, coupled with the range of response between the two TH-types in HCV-infected "speedball" users, suggest impairment in the regulatory mechanism of the TH1-TH2 system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766138     DOI: 10.1016/j.drugalcdep.2006.05.013

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  11 in total

Review 1.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

2.  Hepatitis C virus infection and the risk of coronary disease.

Authors:  Adeel A Butt; Wang Xiaoqiang; Matthew Budoff; David Leaf; Lewis H Kuller; Amy C Justice
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

Review 3.  Infectious and coronary artery disease.

Authors:  Mohammad Saeid Rezaee-Zavareh; Mohammad Tohidi; Amin Sabouri; Mahdi Ramezani-Binabaj; Mohsen Sadeghi-Ghahrodi; Behzad Einollahi
Journal:  ARYA Atheroscler       Date:  2016-01

4.  A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.

Authors:  Anupa Kamat; Vikas Misra; Edana Cassol; Petronela Ancuta; Zhenyu Yan; Cheng Li; Susan Morgello; Dana Gabuzda
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

5.  Cocaine exposure impairs multilineage hematopoiesis of human hematopoietic progenitor cells mediated by the sigma-1 receptor [corrected].

Authors:  Christopher C Nixon; Brandon H Schwartz; Dhaval Dixit; Jerome A Zack; Dimitrios N Vatakis
Journal:  Sci Rep       Date:  2015-03-02       Impact factor: 4.379

6.  Conserved Motifs within Hepatitis C Virus Envelope (E2) RNA and Protein Independently Inhibit T Cell Activation.

Authors:  Nirjal Bhattarai; James H McLinden; Jinhua Xiang; Thomas M Kaufman; Jack T Stapleton
Journal:  PLoS Pathog       Date:  2015-09-30       Impact factor: 6.823

Review 7.  Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.

Authors:  Edana Cassol; Vikas Misra; Susan Morgello; Dana Gabuzda
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-21       Impact factor: 4.147

8.  Human immunodeficiency virus and liver disease: A comprehensive update.

Authors:  Kenneth E Sherman; Marion G Peters; David Thomas
Journal:  Hepatol Commun       Date:  2017-11-06

9.  Identification and Characterization of Biomarkers and Their Role in Opioid Addiction by Integrated Bioinformatics Analysis.

Authors:  Xiuning Zhang; Hailei Yu; Rui Bai; Chunling Ma
Journal:  Front Neurosci       Date:  2020-11-27       Impact factor: 4.677

10.  HCV and HEV: two players in an Egyptian village, a study of prevalence, incidence, and co-infection.

Authors:  Mohammed Elhendawy; Lobna Abo-Ali; Sherief Abd-Elsalam; Maha M Hagras; Ibrahim Kabbash; Loai Mansour; Sherief Atia; Gamal Esmat; Abdel-Raouf Abo-ElAzm; Ferial El-Kalla; Abdelrahman Kobtan
Journal:  Environ Sci Pollut Res Int       Date:  2020-06-12       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.